Page last updated: 2024-08-23

etoposide and Uterine Cervical Dysplasia

etoposide has been researched along with Uterine Cervical Dysplasia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bohle, RM; Büttner, R; Fischbach, J; Horn, LC; Juhasz-Böss, I; Kim, YJ; Mallmann, P; Pahne-Zeppenfeld, J; Rübe, C; Smola, S; Solomayer, EF; Stern, P; Ströder, R; Tharun, L; Walch-Rückheim, B; Wickenhauser, C	1

Other Studies

1 other study(ies) available for etoposide and Uterine Cervical Dysplasia

Article	Year
STAT3/IRF1 Pathway Activation Sensitizes Cervical Cancer Cells to Chemotherapeutic Drugs. Cancer research, 2016, 07-01, Volume: 76, Issue:13 Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Biomarkers, Tumor; Blotting, Western; Cell Proliferation; Cisplatin; Etoposide; Female; Humans; Immunoenzyme Techniques; Interferon Regulatory Factor-1; Neoplasm Staging; Precancerous Conditions; Prognosis; STAT3 Transcription Factor; Tumor Cells, Cultured; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms	2016

Article

Year

STAT3/IRF1 Pathway Activation Sensitizes Cervical Cancer Cells to Chemotherapeutic Drugs.

Cancer research, 2016, 07-01, Volume: 76, Issue:13

Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Biomarkers, Tumor; Blotting, Western; Cell Proliferation; Cisplatin; Etoposide; Female; Humans; Immunoenzyme Techniques; Interferon Regulatory Factor-1; Neoplasm Staging; Precancerous Conditions; Prognosis; STAT3 Transcription Factor; Tumor Cells, Cultured; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms

2016